Trial record 2 of 15 for: Completed Studies | Interventional Studies | Pneumococcal Infections | Poland | Child

Previous Study | Return to List | Next Study

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) (PNEU-PED-EU-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04031846

Recruitment Status : Completed

First Posted : July 24, 2019

Last Update Posted : December 16, 2021

Sponsor:

Information provided by (Responsible Party):

Merck Sharp & Dohme LLC

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	August 5, 2021
Actual Study Completion Date :	August 5, 2021

Submission Cycle	Results Submitted to ClinicalTrials.gov	Results Returned after Quality Control Review
1	March 9, 2022

To Top